Cara Therapeutics (CARA) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Cara Therapeutics, Inc. (NASDAQ:CARA) Held Back By Insufficient Growth Even After Shares Climb 27%
Simply Wall StAug 7 07:41 ET
Cannabis Stock Gainers And Losers From August 5, 2024
BenzingaAug 5 16:30 ET
Cannabis Stock Movers For August 1, 2024
BenzingaAug 1 16:30 ET
Bullish Friday For Marijuana Stocks - GreenGro Technologies, Leafbuyer Techs Among Top Gainers
BenzingaJul 26 16:30 ET
Marijuana Stock Movers For July 25, 2024
BenzingaJul 25 16:30 ET
Cannabis Stock Gainers And Losers From July 24, 2024
BenzingaJul 24 16:30 ET

Comments

Jaguar8

Jun 12 15:02

NEWS

$Cara Therapeutics (CARA.US)$
Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica
Cara Therapeutics announced disappointing results from Part A of their KOURAGE-1 study, evaluating oral difelikefalin for notalgia paresthetica (NP). The drug did not show meaningful clinical benefit over placebo at any dose, leading the company to discontinue the clinical program in NP. The Phase 2/3 trial involved 214 patients, and despite the...

2

Sean Parker

May 1 05:51

Hope it goes well

$Cara Therapeutics (CARA.US)$
CERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing Attributes30/04/2024 09:00AM ET
SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) ("CERo") an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic a...

Moomoo AI

Dec 31, 2023 08:15

Cara Therapeutics' low P/S ratio reflects its declining revenues and bleak future growth projection. Per investors, the company's future may not yield a significant revenue improvement.